7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The selective 5-HT3 receptor antagonist, onansetron, has been assessed in three tests of cognition in the mouse, rat and marmoset. In a habituation test in the mouse, ondansetron facilitated performance in young adult and aged animals, and inhibited an impairment in habituation induced by scopolamine, electrolesions or ibotenic acid lesions of the nucleus basalis magnocellularis. Arecoline failed to improve basal performance in young adult mice but inhibited the impairment caused by scopolamine and lesions of the nucleus basalis magnocellularis. In the T-maze reinforced alternation task in rats, ondansetron and arecoline antagonised a scopolamine-induced impairment. In an object discrimination and reversal learning task in the marmoset, assessed using a Wisconsin General Test Apparatus, ondansetron improved performance in a reversal learning task. We conclude that ondansetron potently improves basal performance in rodent and primate tests of cognition and inhibits the impairments in performance caused by cholinergic deficits.

          Related collections

          Author and article information

          Journal
          Pharmacology Biochemistry and Behavior
          Pharmacology Biochemistry and Behavior
          Elsevier BV
          00913057
          April 1990
          April 1990
          : 35
          : 4
          : 955-962
          Article
          10.1016/0091-3057(90)90385-U
          2140610
          69e530ed-3cdd-4a3f-a5b5-9d6273cb686b
          © 1990

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article